221 filings
8-K
ICCC
Immucell Corp.
9 Apr 24
Entry into a Material Definitive Agreement
5:19pm
8-K
ICCC
Immucell Corp.
9 Apr 24
ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 2024
4:05pm
8-K
ICCC
Immucell Corp.
6 Mar 24
Entry into a Material Definitive Agreement
1:55pm
8-K
ICCC
Immucell Corp.
27 Feb 24
Entry into a Material Definitive Agreement
4:05pm
8-K
ICCC
Immucell Corp.
27 Feb 24
ImmuCell Announces Unaudited Financial Results for
4:05pm
8-K
9bhowwkv41f1utmpb53b
8 Jan 24
ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 2023
4:05pm
8-K
lkxiorort 9vxc
16 Nov 23
Entry into a Material Definitive Agreement
3:22pm
8-K
xj5h57azsgmvpjjmpwof
13 Nov 23
ImmuCell Announces Unaudited Financial Results for
4:05pm
8-K
jna74 rfoa5txgxl2
5 Oct 23
ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 2023
4:05pm
8-K
neffd73 md3fhas
10 Aug 23
ImmuCell Announces Unaudited Financial Results for
4:05pm
8-K
wgnhbuukguup
21 Jul 23
Entry into a Material Definitive Agreement
9:04am
8-K
ifn35s
11 Jul 23
ImmuCell Announces Preliminary, Unaudited Sales Results for Q2 2023
4:05pm
8-K
zjhrsb1hf0s4tw4
29 Jun 23
ImmuCell Announces Change in Timing of Anticipated FDA Submission
1:02pm
8-K
e6q 4qaropl8bwqrb
21 Jun 23
ImmuCell Appoints Bryan K. Gathagan to Board of Directors
4:05pm
8-K
hx8mi5s eoddu
11 May 23
ImmuCell Announces Unaudited Financial Results for
4:06pm
8-K
robl4ox
5 Apr 23
ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 2023
4:05pm
8-K
z2rcd
28 Feb 23
Departure of Directors or Certain Officers
9:24am
8-K
8mfrgzrrr2j6azgei
21 Feb 23
ImmuCell Announces Unaudited Financial Results for
4:06pm
8-K
go5npl6rj2a7frt5blu
1 Feb 23
Departure of Directors or Certain Officers
5:25pm
8-K
5xe5512rtcu olpsqm1
9 Jan 23
Results of Operations and Financial Condition
4:10pm